Dad in agonising pain 'almost died' after weight loss jab mistake
A 44-year-old dad from Oldham, Edd Langmead, who bought Mounjaro weight loss injections online after a 12+ month NHS waiting list, developed life-threatening gangrenous cholecystitis requiring emergency gallbladder removal surgery, which doctors believe was linked to his rapid weight loss.
Dad Suffers Life-Threatening Gallbladder Condition After Weight Loss Jab Mistake
A 44-year-old father who thought he had trapped wind after using weight loss injections was rushed to hospital with a rotting gallbladder - an infection that doctors said could have killed him. Edd Langmead, from Oldham, was blue-lighted to hospital after being found doubled over in pain on his living room floor. Surgeons discovered he had gangrenous cholecystitis, a life-threatening condition where gallbladder tissue dies, and performed emergency surgery to remove the organ. The infection had also spread into his stomach and lungs.
Langmead, a musician and father of two, started his weight loss journey in May 2025 after struggling with his weight all his life, at his heaviest weighing 20st 7lbs. He told his GP he was desperate to lose weight but was told the waiting list for weight-loss medication was more than 12 months. The 44-year-old then bought Mounjaro from an online pharmacy and saw “instant” results, losing 5st 13lb in under a year. However, after a rise in costs he switched to a cheaper weight loss jab before returning to Mounjaro. On March 9 he began experiencing pain he believed was trapped wind, but three days later his partner called an ambulance. “I couldn’t sit or lie down without being in pain and it just kept getting worse and worse,” Edd said. “All I could think of was leaving my kids without a dad.”
After his ordeal, Edd has urged anyone wanting to use weight loss injections to get them through their GP so they can be properly monitored. “I’ve gone from being the healthiest I’ve ever felt since I was a teenager to now, I feel like I’m in my nineties,” he said. “Make sure you go get regular blood tests. It’s not worth the risk.” A spokesman for Lilly, which manufactures Mounjaro, said: “Patient safety is Lilly’s top priority and we actively monitor, evaluate, and report safety information for all our medicines to the MHRA. The Mounjaro (tirzepatide) Patient Information Leaflet warns that cholecystitis (infection of the gallbladder) is an uncommon side effect (may affect up to 1 in 100 people).”
Source: Read original article